Patient advocacy groups will now benefit from a new, centralized source of information about cancer drug products or indications anticipated to enter the Canadian market.
The Cancer Drug Pipeline Information for Patient Advocacy Groups is a collaboration between the Canadian Cancer Action Network (…
See CDR Update 111 for important news and information regarding the CADTH Common Drug Review.
OTTAWA, September 25, 2015 — CADTH has launched an important initiative to help Canadian health care decision-makers provide timely and appropriate medical imaging services to patients.
As a first step, CADTH will update the Canadian Medical Imaging Inventory through a survey of health care…
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada
The 2016 CADTH Symposium Program Committee invites submissions of abstracts for workshops, panels, breakfast sessions, and oral and poster presentations, related to the theme of Evidence for Everyone: Expanding the Reach of Health Technology Assessment.
Abstracts must be submitted online at Call…
Register by September 21st for the next lecture, which will be hosted by Dr. Art Sedrakyan, Professor of Healthcare Policy and Research in Cardiothoracic Surgery, Weill Cornell Medical College.
In the United States, 63% of all hospital stays — or more than 24 million hospital stays annually —…
Final Environmental Scanning reports are now available for the CADTH project on Health Interventions in Ambulatory Cancer Care Centres.
The draft recommendations report for CADTH’s project on Drugs for Chronic Hepatitis C Infection is now available for feedback from all interested stakeholders.
A draft environmental scanning document on Health Interventions in Ambulatory Cancer Care Centres is available for feedback from all interested stakeholders.
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website…
The high cost of cancer medications across Canada is examined by Paul Taylor, Sunnybrook Health Sciences Centre’s Patient Navigation Advisor, in his latest Your Health Matters column.
Dr. Mona Sabharwal, Executive Director of the CADTH pan-Canadian Oncology Drug Review (pCODR), was interviewed for…
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on "Submit." For information about the patient input process or for additional instructions, please see the Patient Input page of our website…